Opens in a new tab
Skip to content
Claire Bevis Mott
Claire Bevis Mott

EDX Medical Group Appoints Product Development Director

EDX Medical Group has today announced the appointment of Claire Bevis-Mott as Director of Product Development. Mrs Bevis-Mott joins EDX Medical while the Company is accelerating the development of new diagnostic products to help meet global demand from healthcare providers.

Mrs Bevis-Mott is a proven scientific leader in the life sciences sector, working in leadership and management positions with companies including Illumina Ltd where she worked for 17 years commercialising numerous products and received an “Accomplished Inventor” award as the most prolific female inventor within the Product Development team.  Previously, she held a research post with the Medical Research Council.

Claire Bevis-Mott commented: “I am excited to be joining the EDX Medical team which is clearly committed to bringing innovative diagnostic products to patients. The need for rapid diagnosis and personalised treatments across a wide range of diseases has never been greater. Having taken complex products to market, I have deep experience   in all phases of the product lifecycle and am passionate about the creation and delivery of novel solutions that can make a difference to patients.”

Professor Sir Chris Evans OBE, founder of EDX Medical, commented: “We’re thrilled to welcome Claire to EDX Medical as she has demonstrated over many years, particularly with a world leader in human genomics such as Illumina, a tremendous ability to develop class-leading testing products.  Claire’s proven expertise in taking projects from laboratory into marketable products fits hand in glove with our vision to deliver the most advanced diagnostic tests to patients.”

Dr Mike Hudson, CEO of EDX Medical, commented: “We are delighted that Claire is joining our international development team at a time when we are growing our portfolio of products and services. Her outstanding project management skills and understanding behind the technical delivery of complex genomic products will immediately enhance our ability to deliver ‘best-in-class’ innovative products.”

Claire Bevis Mott
Claire Bevis Mott
Claire Bevis Mott
Claire Bevis Mott

Recent articles

The Guardian logo in bold black text on a light background.
September 30, 2026

EDX Medical featured in The Guardian

A feature highlighting the growing importance of advanced health screening and early disease detection appeared…

Read more →
White bold text reading “Arnold Clark” on a dark grey background, representing the Arnold Clark Group’s commitment to employee health screening and wellbeing screening.
September 17, 2026

Major Employee Health and Wellbeing Screening Contract With Arnold Clark Group

EDX Medical is delighted is delighted to announce that it has entered into an initial…

Read more →
Four men stand indoors holding a sign that reads “Scottish Prostate Cancer Initiative. Early detection saves lives.” The men are smiling, and the background features dark wood panelling—a powerful reminder of the importance of Scottish Prostate Cancer testing events for early diagnosis and improved outcomes.
August 27, 2026

New testing events for Scottish Prostate Cancer Initiative

EDX Medical, as the lead delivery partner in the Scottish Prostate Cancer Initiative, has commenced…

Read more →
The image shows the "edx medical" logo. "edx" is written in lowercase white letters inside a blue hexagon, with the word "medical" in blue lowercase text to the right of the hexagon.

The Scottish Prostate Cancer Initiative

EDX Medical is launching a new employee health screening service offering a comprehensive range of tests.